Drug intelligence / Profile preview

PF-004390

Development stage: Unknown
Modality: Small Molecules
Administration: Topical (eye Drops)

Overview

PF-004390 is an investigational drug formulated as eye drops. It has been studied in clinical trials designed to evaluate the efficacy of over-the-counter (OTC) eye drops for treating red eyes in healthy adults. The exact mechanism of action and therapeutic target of PF-004390 have not been publicly detailed. The drug appears to be developed for ocular use, likely targeting symptoms such as eye redness or irritation. The clinical trial context indicates it is a topical ophthalmic formulation intended to demonstrate therapeutic equivalence with other OTC eye drop products.

Other names: F# PF-004390 Eye Drops

Beyond the preview

Go deeper on PF-004390.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PF-004390.

Explore the full profile